top of page
Image-empty-state.png

Evelina Tacconelli

Director

Email:

Phone:

+39 045 812 8243

Short biography

Evelina Tacconelli is a Full Professor of Infectious Diseases at the University of Verona, Italy and Head of the DZIF Clinical Research Unit on healthcare associated infections and antimicrobial resistance at the Tübingen University, Germany. She has been Lecturer on Medicine at the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, USA. She was recipient of award from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) for research excellence. Consultant for WHO, ECDC and EMA on antimicrobial resistance and infection control. Her main areas of scientific interest are epidemiology, clinical and therapeutic aspects of healthcare-associated infections and preventive measures aimed to reduce the spreading of antibiotic-resistant bacteria. Co-coordinator of the Unit of research on healthcare-associated and antibiotic-resistant bacterial infections (TTU-HAARBI) within the German Center for Infectious Diseases (DZIF). She is the ESCMID Guideline Officer for Infectious Diseases and Clinical Microbiology. Member of the SAB of the JPI-AMR. Chair of the 2018 WHO Priority List of Pathogens for R&D of new antibiotics. Chair of the European Committee of Infection Control (EUCIC). Chair of the ESCMID guidelines on prevention and therapy of infections due to multidrug-resistant Gram negative bacteria (MDR-GN) and EUCIC guideline on decolonization procedures for patients colonized with MDR-GN. Involved (partner site or coordinator) in many European studies on prevention and therapy of infections caused by antibiotic-resistant bacteria financed by European Commission, WHO, JPI-AMR, Horizon2020, DG-Sanco, IMI, and DZIF. She serves on the International Advisory Board of Lancet Infectious Diseases, Editorial Board of Journal of Antimicrobial Chemotherapy and Scientific Committee of Clinical Microbiology and Infection. Author and co-author of more than 200 papers listed in SCI-JCR and NIH Medline. In April 2023 Evelina was appointed as Chief Scientific Officer (CSO) of the Ecraid Foundation.

Projects

ORCHESTRA

MPX-RESPONSE

EU-RESPONSE

ENACT-SOS COVID

COMBACTE-NET-EXPECT

ECRAID-Base

AMR Travel Tool

EPI-Net

Sentinella

ENACT-REACT COVID (MS)

Chemsex MSM

COHERENCE

PRIMAVERA

VALUE-DX

ENACT-REACT COVID (LTFU)

ARCH-NET

VACCELERATE

Excellence Centres

WHO BPPL

SOLIDARITY-Italy

ENACT-REACT COVID (RA)

Publications

31/10/24

Archives of Public Health

Socio-demographic and clinical predictors of post-acute, mid-and long-term psychological sequelae of COVID-19: a two-year cross-sectional investigation on 1317 patients at the University Hospital of Verona

29/9/24

Journal of Fungi

Tracking Candidemia Trends and Antifungal Resistance Patterns across Europe: An In-Depth Analysis of Surveillance Systems and Surveillance Studies

23/10/24

Frontiers in Public Health

Community case study for surveillance and early case-detection of SARS-CoV-2 infections across high-risk key populations: the Sentinella programme

19/9/24

mSphere

The gut microbiota as an early predictor of COVID-19 severity

15/10/24

Journal of Infection

Pooled analysis of the MANTICO 2 and MONET randomized controlled trials comparing drug efficacy for early treatment of COVID-19 during Omicron waves

9/9/24

Scientific Reports

Chemosensory assessment and impact on quality of life in neurosensorial cluster of the post COVID 19 syndrome

bottom of page